227 research outputs found

    ADAMTS15 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif, 15)

    Get PDF
    Review on ADAMTS15, with data on DNA/RNA, on the protein encoded and where the gene is implicated

    ADAMTS12 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif, 12)

    Get PDF
    Review on ADAMTS12, with data on DNA/RNA, on the protein encoded and where the gene is implicated

    Surface features, rotation and atmospheric variability of ultra cool dwarfs

    Get PDF
    Photometric I band light curves of 21 ultra cool M and L dwarfs are presented. Variability with amplitudes of 0.01 to 0.055 magnitudes (RMS) with typical timescales of an hour to several hours are discovered in half of these objects. Periodic variability is discovered in a few cases, but interestingly several variable objects show no significant periods, even though the observations were almost certainly sensitive to the expected rotation periods. It is argued that in these cases the variability is due to the evolution of the surface features on timescales of a few hours. This is supported in the case of 2M1145 for which no common period is found in two separate light curves. It is speculated that these features are photospheric dust clouds, with their evolution possibly driven by rotation and turbulence. An alternative possibility is magnetically-induced surface features. However, chromospheric activity undergoes a sharp decrease between M7 and L1, whereas a greater occurrence of variability is observed in objects later than M9, lending support to the dust interpretation.Comment: To appear in "Ultracool Dwarf Stars" (Lecture Notes in Physics), H.R.A. Jones, I. Steele (eds), Springer-Verlag, 2001. Also available from http://www.mpia-hd.mpg.de/homes/calj/ultra.htm

    Multiplicity of young brown dwarfs in Cha I

    Get PDF
    How frequent are brown dwarf binaries? Do brown dwarfs have planets? Are current theoretical pre-main-sequence evolutionary tracks valid down to the substellar regime? - Any detection of a companion to a brown dwarf takes us one step forward towards answering these basic questions of star formation. We report here on a search for spectroscopic and visual companions to young brown dwarfs in the Cha I star forming cloud. Based on spectra taken with UVES at the VLT, we found significant radial velocity (RV) variations for five bona-fide and candidate brown dwarfs in Cha I. They can be caused by either a (substellar or planetary) companion or stellar activity. A companion causing the detected RV variations would have about a few Jupiter masses. We are planning further UVES observations in order to explore the nature of the detected RV variations. We also found that the RV dispersion is only ~ 2km/s indicating that there is probably no run-away brown dwarf among them. Additionally a search for companions by direct imaging with the HST and SOFI (NTT) has yielded to the detection of a few companion candidates in larger orbits.Comment: Conference proceeding "Origins of stars and planets: The VLT view", ESO, Garching, April 24-27 200

    Variability of Brown Dwarfs

    Full text link
    Brown dwarfs constitute a missing link between low-mass stars and giant planets. Their atmospheres display chemical species typical of planets, and one could wonder whether they also have weather-like patterns. While brown dwarf surface features cannot be directly resolved, the photometric and spectroscopic modulations induced by these features, as they rotate in and out of view, provide a wealth of information on the evolution of their atmosphere. A review of brown dwarfs variability through the L, T and Y spectral types sequence is presented, as well as the constraints that they set on the nature of weather-like patterns on their surface.Comment: Accepted chapter in the "Handbook of Exoplanets"; Springe

    Human DESC1 serine protease confers tumorigenic properties to MDCK cells and it is upregulated in tumours of different origin

    Get PDF
    Proteolysis of the extracellular matrix components plays a crucial role in the regulation of the cellular and physiological processes, and different pathologies have been associated with the loss or gain of function of proteolytic enzymes. DESC1 (differentially expressed in squamous cell carcinoma gene 1), a member of the TTSP (type II transmembrane serine protease) family of serine proteases, is an epithelial-specific enzyme that has been found downregulated in squamous cell carcinoma of the head and neck region. We describe new properties of DESC1 suggesting that this protease may be involved in the progression of some type of tumours. Thus, this enzyme hydrolyses some extracellular matrix components, such as fibronectin, gelatin or fibrinogen. Moreover, Madin–Darby canine kidney (MDCK) cells expressing exogenous human DESC1 acquire properties associated with tumour growth such as enhanced motility and an increase of tubular forms in a 3D collagen lattice following HGF treatment. Finally, we generated polyclonal anti-DESC1 antibodies and immunohistochemical analysis in tissues different from head and neck region indicated that this protease was overexpressed in tumours of diverse origins. Taken together, our results suggest that DESC1 could be considered as a potential therapeutic target in some type of tumours

    Site-selective protein-modification chemistry for basic biology and drug development.

    Get PDF
    Nature has produced intricate machinery to covalently diversify the structure of proteins after their synthesis in the ribosome. In an attempt to mimic nature, chemists have developed a large set of reactions that enable post-expression modification of proteins at pre-determined sites. These reactions are now used to selectively install particular modifications on proteins for many biological and therapeutic applications. For example, they provide an opportunity to install post-translational modifications on proteins to determine their exact biological roles. Labelling of proteins in live cells with fluorescent dyes allows protein uptake and intracellular trafficking to be tracked and also enables physiological parameters to be measured optically. Through the conjugation of potent cytotoxicants to antibodies, novel anti-cancer drugs with improved efficacy and reduced side effects may be obtained. In this Perspective, we highlight the most exciting current and future applications of chemical site-selective protein modification and consider which hurdles still need to be overcome for more widespread use.We thank FCT Portugal (FCT Investigator to G.J.L.B.), the EU (Marie-Curie CIG to G.J.L.B. and Marie-Curie IEF to O.B.) and the EPSRC for funding. G.J.L.B. is a Royal Society University Research Fellow.This is the author accepted manuscript. The final version is available from NPG via http://dx.doi.org/10.1038/nchem.239
    • 

    corecore